Brief: Elite Pharmaceuticals Gets FDA Approval For Generic Version Of Allergan's Pain Treatment Tablets
20/11/2018 16:15
Nov 20 (Reuters) - Elite Pharmaceuticals Inc ELTP.PK :
* ELITE PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
HYDROCODONE AND
ACETAMINOPHEN COMBO
* ELITE PHARMACEUTICALS - GOT FDA APPROVAL FOR APPLICATION
FOR
GENERIC VERSION OF NORCO (HYDROCODONE BITARTRATE & ACETAMINOPHEN
TABLETS, USP CII) TABLETS
Source text for Eikon: ID:nGNX17DwmN
Further company coverage: ELTP.PK AGN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elite Pharmaceuticals
See all newsBrief: Elite Pharmaceuticals Receives Approval From FDA On May 16, For A Generic Version Of Methotrexate Sodium 2.5 Mg Tablets
Brief: Lannett Enters Into Distribution Agreement For Dantrolene Capsules
Brief: Lannett Enters Into Distribution Agreement For Generic Adderall
Brief: Elite Pharmaceuticals Gets FDA Approval For Generic Version Of Allergan's Pain Treatment Tablets
Brief: Elite Pharmaceuticals Files ANDA For Codeine And Acetaminophen Combo